In the BioHarmony Drug Report Database
Valproic acid
Depakene, Stavzor (valproic acid) is a small molecule pharmaceutical. Valproic acid was first approved as Depakene on 1982-01-01. It is used to treat absence epilepsy, alzheimer disease, bipolar disorder, complex partial epilepsy, and epilepsy amongst others in the USA. It is known to target histone deacetylase 1.
Trade Name
|
Depakene, Stavzor |
|---|---|
Common Name
|
valproic acid |
ChEMBL ID
|
CHEMBL109 |
Indication
|
absence epilepsy, alzheimer disease, bipolar disorder, complex partial epilepsy, epilepsy, mood disorders |
Drug Class
|
Image (chem structure or protein)